{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T19:53:44Z","timestamp":1778270024980,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["LA2937\/4-1"],"award-info":[{"award-number":["LA2937\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["SH1223\/1-1"],"award-info":[{"award-number":["SH1223\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["SFB 1066"],"award-info":[{"award-number":["SFB 1066"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["331065168"],"award-info":[{"award-number":["331065168"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"crossref","award":["16GW0319K"],"award-info":[{"award-number":["16GW0319K"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"crossref"}]},{"name":"European Research Council","award":["864121"],"award-info":[{"award-number":["864121"]}]},{"name":"European Research Council","award":["101040996"],"award-info":[{"award-number":["101040996"]}]},{"name":"Higher Education Commission of Pakistan and German Academic Exchange Services"},{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nanomedicine holds promise for potentiating drug combination therapies. Increasing (pre)clinical evidence is available exemplifying the value of co-formulating and co-delivering different drugs in modular nanocarriers. Taxanes like paclitaxel (PTX) are widely used anticancer agents, and commonly combined with corticosteroids like dexamethasone (DEX), which besides for suppressing inflammation and infusion reactions, are increasingly explored for modulating the tumor microenvironment towards enhanced nano-chemotherapy delivery and efficacy. We here set out to develop a size- and release rate-tunable polymeric micelle platform for co-delivery of taxanes and corticosteroids. We synthesized amphiphilic mPEG-<jats:italic>b<\/jats:italic>-p(HPMAm-Bz) block copolymers of various molecular weights and used them to prepare PTX and DEX single- and double-loaded micelles of different sizes. Both drugs could be efficiently co-encapsulated, and systematic comparison between single- and co-loaded formulations demonstrated comparable physicochemical properties, encapsulation efficiencies, and release profiles. Larger micelles showed slower drug release, and DEX release was always faster than PTX. The versatility of the platform was exemplified by co-encapsulating two additional taxane-corticosteroid combinations, demonstrating that drug hydrophobicity and molecular weight are key properties that strongly contribute to drug retention in micelles. Altogether, our work shows that mPEG-<jats:italic>b<\/jats:italic>-p(HPMAm-Bz) polymeric micelles serve as a tunable and versatile nanoparticle platform for controlled co-delivery of taxanes and corticosteroids, thereby paving the way for using these micelles as a modular carrier for multidrug nanomedicine.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s13346-023-01465-x","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T14:02:31Z","timestamp":1699970551000},"page":"2642-2654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tunable polymeric micelles for taxane and corticosteroid co-delivery"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2238-6525","authenticated-orcid":false,"given":"Armin Azadkhah","family":"Shalmani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alec","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaheer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Sheybanifard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahaf","family":"Mihyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Miriam","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim E.","family":"Hennink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Kiessling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josbert M.","family":"Metselaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1090-6805","authenticated-orcid":false,"given":"Twan","family":"Lammers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6477-8127","authenticated-orcid":false,"given":"Quim","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"1465_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","volume":"22","author":"H Jin","year":"2022","unstructured":"Jin H, Wang L, Bernards R. Rational combinations of targeted cancer therapies: background, advances and challenges. Nat Rev Drug Discov. 2022;22:213\u201334. https:\/\/doi.org\/10.1038\/s41573-022-00615-z.","journal-title":"Nat Rev Drug Discovery"},{"key":"1465_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","volume":"603","author":"P Jaaks","year":"2022","unstructured":"Jaaks P, Coker EA, Vis DJ, Edwards O, Carpenter EF, Leto SM, et al. Effective drug combinations in breast, colon and pancreatic cancer cells. Nature. 2022;603:166\u201373. https:\/\/doi.org\/10.1038\/s41586-022-04437-2.","journal-title":"Nature"},{"key":"1465_CR3","doi-asserted-by":"publisher","unstructured":"Sudalagunta P, Silva MC, Canevarolo RR, Alugubelli RR, DeAvila G, Tungesvik A, et al. A pharmacodynamic model of clinical synergy in multiple myeloma. EBioMedicine 2020;54. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102716.","DOI":"10.1016\/j.ebiom.2020.102716"},{"key":"1465_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discovery. 2021;20:101\u201324. https:\/\/doi.org\/10.1038\/s41573-020-0090-8.","journal-title":"Nat Rev Drug Discovery"},{"key":"1465_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41565-022-01265-3","volume":"18","author":"AM Sofias","year":"2023","unstructured":"Sofias AM, Lammers T. Multidrug nanomedicine. Nat Nanotechnol. 2023;18:104\u20136. https:\/\/doi.org\/10.1038\/s41565-022-01265-3.","journal-title":"Nat Nanotechnol"},{"key":"1465_CR6","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1200\/JCO.2017.77.6112","volume":"36","author":"JE Lancet","year":"2018","unstructured":"Lancet JE, Uy GL, Cortes JE, Newell LF, Lin TL, Ritchie EK, et al. Cpx-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid leukemia. J Clin Oncol. 2018;36:2684\u201392. https:\/\/doi.org\/10.1200\/JCO.2017.77.6112.","journal-title":"J Clin Oncol"},{"key":"1465_CR7","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/MT.2014.27","volume":"22","author":"E Blanco","year":"2014","unstructured":"Blanco E, Sangai T, Wu S, Hsiao A, Ruiz-Esparza GU, Gonzalez-Delgado CA, et al. Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K\/Akt\/mTOR pathway. Mol Ther. 2014;22:1310\u20139. https:\/\/doi.org\/10.1038\/MT.2014.27.","journal-title":"Mol Ther"},{"key":"1465_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/S13346-020-00740-5","volume":"10","author":"JM Metselaar","year":"2020","unstructured":"Metselaar JM, Lammers T. Challenges in nanomedicine clinical translation. Drug Deliv Transl Res. 2020;10:721\u20135. https:\/\/doi.org\/10.1007\/S13346-020-00740-5.","journal-title":"Drug Deliv Transl Res"},{"key":"1465_CR9","doi-asserted-by":"publisher","first-page":"e791","DOI":"10.1016\/S2666-7568(21)00255-5","volume":"2","author":"Y Kogure","year":"2021","unstructured":"Kogure Y, Iwasawa S, Saka H, Hamamoto Y, Kada A, Hashimoto H, et al. Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial. Lancet Healthy Longev. 2021;2:e791-800. https:\/\/doi.org\/10.1016\/S2666-7568(21)00255-5.","journal-title":"The Lancet Healthy Longevity"},{"key":"1465_CR10","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","volume":"397","author":"S Loibl","year":"2021","unstructured":"Loibl S, Poortmans P, Morrow M, Denkert C, Curigliano G. Breast cancer. Lancet. 2021;397:1750\u201369. https:\/\/doi.org\/10.1016\/S0140-6736(20)32381-3.","journal-title":"The Lancet"},{"key":"1465_CR11","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMOA1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691\u2013703. https:\/\/doi.org\/10.1056\/NEJMOA1304369.","journal-title":"N Engl J Med"},{"key":"1465_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/J.JCONREL.2017.09.026","volume":"267","author":"F Wang","year":"2017","unstructured":"Wang F, Porter M, Konstantopoulos A, Zhang P, Cui H. Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy. J Control Release. 2017;267:100\u201318. https:\/\/doi.org\/10.1016\/J.JCONREL.2017.09.026.","journal-title":"J Control Release"},{"key":"1465_CR13","doi-asserted-by":"publisher","unstructured":"Nia HT, Munn LL, Jain RK. Physical traits of cancer. Science. 2020;370. https:\/\/doi.org\/10.1126\/SCIENCE.AAZ0868.","DOI":"10.1126\/SCIENCE.AAZ0868"},{"key":"1465_CR14","doi-asserted-by":"publisher","unstructured":"Zhang YR, Lin R, Li HJ, He W ling, Du JZ, Wang J. Strategies to improve tumor penetration of nanomedicines through nanoparticle design.\u00a0Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019;11:e1519. https:\/\/doi.org\/10.1002\/WNAN.1519.","DOI":"10.1002\/WNAN.1519"},{"key":"1465_CR15","doi-asserted-by":"publisher","first-page":"7195","DOI":"10.1021\/ACSNANO.5B02017","volume":"9","author":"J Wang","year":"2015","unstructured":"Wang J, Mao W, Lock LL, Tang J, Sui M, Sun W, et al. The role of micelle size in tumor accumulation, penetration, and treatment. ACS Nano. 2015;9:7195\u2013206. https:\/\/doi.org\/10.1021\/ACSNANO.5B02017.","journal-title":"ACS Nano"},{"key":"1465_CR16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nnano.2011.166","volume":"6","author":"H Cabral","year":"2011","unstructured":"Cabral H, Matsumoto Y, Mizuno K, Chen Q, Murakami M, Kimura M, et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011;6:815\u201323. https:\/\/doi.org\/10.1038\/nnano.2011.166.","journal-title":"Nat Nanotechnol"},{"key":"1465_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/J.JCONREL.2014.12.018","volume":"201","author":"IA Khawar","year":"2015","unstructured":"Khawar IA, Kim JH, Kuh HJ. Improving drug delivery to solid tumors: priming the tumor microenvironment. J Control Release. 2015;201:78\u201389. https:\/\/doi.org\/10.1016\/J.JCONREL.2014.12.018.","journal-title":"J Control Release"},{"key":"1465_CR18","doi-asserted-by":"publisher","unstructured":"Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med. 2008;358:2482\u20132494. https:\/\/doi.org\/10.1056\/NEJMra0706547","DOI":"10.1056\/NEJMra0706547"},{"key":"1465_CR19","doi-asserted-by":"publisher","unstructured":"Facon T, Kumar S, Plesner T, Orlowski RZ, Moreau P, Bahlis N, et al. Daratumumab plus lenalidomide and dexamethasone for untreated myeloma. N Engl J Med. 2019;380:2104\u20132115. https:\/\/doi.org\/10.1056\/NEJMoa1817249","DOI":"10.1056\/NEJMoa1817249"},{"key":"1465_CR20","doi-asserted-by":"publisher","unstructured":"Teply BA, Luber B, Denmeade SR, Antonarakis ES. The influence of prednisone on the efficacy of docetaxel in men with metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2016;19:72\u20138. https:\/\/doi.org\/10.1038\/pcan.2015.53.","DOI":"10.1038\/pcan.2015.53"},{"key":"1465_CR21","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(10)61389-X","volume":"376","author":"JS De Bono","year":"2010","unstructured":"De Bono JS, Oudard S, Ozguroglu M, Hansen S, MacHiels JP, Kocak I, et al. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet. 2010;376:1147\u201354. https:\/\/doi.org\/10.1016\/S0140-6736(10)61389-X.","journal-title":"The Lancet"},{"key":"1465_CR22","doi-asserted-by":"publisher","first-page":"6396","DOI":"10.1021\/ACSNANO.8B07865","volume":"13","author":"JD Martin","year":"2019","unstructured":"Martin JD, Panagi M, Wang C, Khan TT, Martin MR, Voutouri C, et al. Dexamethasone increases cisplatin-loaded nanocarrier delivery and efficacy in metastatic breast cancer by normalizing the tumor microenvironment. ACS Nano. 2019;13:6396\u2013408. https:\/\/doi.org\/10.1021\/ACSNANO.8B07865.","journal-title":"ACS Nano"},{"key":"1465_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JCONREL.2018.12.004","volume":"294","author":"L Zhang","year":"2019","unstructured":"Zhang L, Su H, Liu Y, Pang N, Li J, Qi XR. Enhancing solid tumor therapy with sequential delivery of dexamethasone and docetaxel engineered in a single carrier to overcome stromal resistance to drug delivery. J Control Release. 2019;294:1\u201316. https:\/\/doi.org\/10.1016\/J.JCONREL.2018.12.004.","journal-title":"J Control Release"},{"key":"1465_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.JCONREL.2018.04.010","volume":"279","author":"H Popilski","year":"2018","unstructured":"Popilski H, Abtew E, Schwendeman S, Domb A, Stepensky D. Efficacy of paclitaxel\/dexamethasone intra-tumoral delivery in treating orthotopic mouse breast cancer. J Control Release. 2018;279:1\u20137. https:\/\/doi.org\/10.1016\/J.JCONREL.2018.04.010.","journal-title":"J Control Release"},{"key":"1465_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/J.JCONREL.2021.02.031","volume":"332","author":"M Ghezzi","year":"2021","unstructured":"Ghezzi M, Pescina S, Padula C, Santi P, Del Favero E, Cant\u00f9 L, et al. Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release. 2021;332:312\u201336. https:\/\/doi.org\/10.1016\/J.JCONREL.2021.02.031.","journal-title":"J Control Release"},{"key":"1465_CR26","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1021\/ACSNANO.5B00929","volume":"9","author":"Y Shi","year":"2015","unstructured":"Shi Y, Van Der Meel R, Theek B, Oude Blenke E, Pieters EHE, Fens MHAM, et al. Complete regression of xenograft tumors upon targeted delivery of paclitaxel via \u220f - \u220f stacking stabilized polymeric micelles. ACS Nano. 2015;9:3740\u201352. https:\/\/doi.org\/10.1021\/ACSNANO.5B00929.","journal-title":"ACS Nano"},{"key":"1465_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/J.BIOMATERIALS.2020.120432","volume":"266","author":"C Liang","year":"2021","unstructured":"Liang C, Bai X, Qi C, Sun Q, Han X, Lan T, et al. \u03a0 electron-stabilized polymeric micelles potentiate docetaxel therapy in advanced-stage gastrointestinal cancer. Biomaterials. 2021;266: 120432. https:\/\/doi.org\/10.1016\/J.BIOMATERIALS.2020.120432.","journal-title":"Biomaterials"},{"key":"1465_CR28","doi-asserted-by":"publisher","first-page":"15495","DOI":"10.1021\/ACS.LANGMUIR.8B03576","volume":"34","author":"M Bagheri","year":"2018","unstructured":"Bagheri M, Bresseleers J, Varela-Moreira A, Sandre O, Meeuwissen SA, Schiffelers RM, et al. Effect of formulation and processing parameters on the size of mPEG- b-p(HPMA-Bz) polymeric micelles. Langmuir. 2018;34:15495\u2013506. https:\/\/doi.org\/10.1021\/ACS.LANGMUIR.8B03576.","journal-title":"Langmuir"},{"key":"1465_CR29","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1007\/S11095-016-1954-9","volume":"33","author":"F Sun","year":"2016","unstructured":"Sun F, Jaspers TCC, van Hasselt PM, Hennink WE, van Nostrum CF. A mixed micelle formulation for oral delivery of vitamin K. Pharm Res. 2016;33:2168\u201379. https:\/\/doi.org\/10.1007\/S11095-016-1954-9.","journal-title":"Pharm Res"},{"key":"1465_CR30","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.1021\/LA048354H","volume":"20","author":"O Soga","year":"2004","unstructured":"Soga O, Van Nostrum CF, Ramzi A, Visser T, Soulimani F, Frederik PM, et al. Physicochemical characterization of degradable thermosensitive polymeric micelles. Langmuir. 2004;20:9388\u201395. https:\/\/doi.org\/10.1021\/LA048354H.","journal-title":"Langmuir"},{"key":"1465_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2020.119409","volume":"584","author":"M Sheybanifard","year":"2020","unstructured":"Sheybanifard M, Beztsinna N, Bagheri M, Buhl EM, Bresseleers J, Varela-Moreira A, et al. Systematic evaluation of design features enables efficient selection of \u03a0 electron-stabilized polymeric micelles. Int J Pharm. 2020;584:119409. https:\/\/doi.org\/10.1016\/J.IJPHARM.2020.119409.","journal-title":"Int J Pharm"},{"key":"1465_CR32","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41551-018-0234-x","volume":"2","author":"Y Lu","year":"2018","unstructured":"Lu Y, Yue Z, Xie J, Wang W, Zhu H, Zhang E, et al. Micelles with ultralow critical micelle concentration as carriers for drug delivery. Nat Biomed Eng. 2018;2:318\u201325. https:\/\/doi.org\/10.1038\/s41551-018-0234-x.","journal-title":"Nature Biomedical Engineering"},{"key":"1465_CR33","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1021\/ACS.BIOMAC.2C01261","volume":"24","author":"AA Shalmani","year":"2023","unstructured":"Shalmani AA, Ahmed Z, Sheybanifard M, Wang A, Weiler M, Buhl EM, et al. Effect of radical polymerization method on pharmaceutical properties of \u03a0 electron-stabilized HPMA-based polymeric micelles. Biomacromol. 2022. https:\/\/doi.org\/10.1021\/ACS.BIOMAC.2C01261.","journal-title":"Biomacromol"},{"key":"1465_CR34","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/J.JCONREL.2022.01.023","volume":"343","author":"S Pandit","year":"2022","unstructured":"Pandit S, Palvai S, Massaro NP, Pierce JG, Brudno Y. Tissue-reactive drugs enable materials-free local depots. J Control Release. 2022;343:142\u201351. https:\/\/doi.org\/10.1016\/J.JCONREL.2022.01.023.","journal-title":"J Control Release"},{"key":"1465_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.bjc.6601303","volume":"90","author":"JS Kloover","year":"2004","unstructured":"Kloover JS, Den Bakker MA, Gelderblom H, Van Meerbeeck JP. Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens. Br J Cancer. 2004;90:304\u20135. https:\/\/doi.org\/10.1038\/sj.bjc.6601303.","journal-title":"Br J Cancer"},{"key":"1465_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1093\/NEUONC\/NOZ034","volume":"21","author":"SM Chang","year":"2019","unstructured":"Chang SM, Messersmith H, Ahluwalia M, Andrews D, Brastianos PK, Gaspar LE, et al. Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines. Neuro Oncol. 2019;21:424\u20137. https:\/\/doi.org\/10.1093\/NEUONC\/NOZ034.","journal-title":"Neuro Oncol"},{"key":"1465_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/J.IJPHARM.2007.07.042","volume":"349","author":"AO Nornoo","year":"2008","unstructured":"Nornoo AO, Osborne DW, Chow DSL. Cremophor-free intravenous microemulsions for paclitaxel: I: formulation, cytotoxicity and hemolysis. Int J Pharm. 2008;349:108\u201316. https:\/\/doi.org\/10.1016\/J.IJPHARM.2007.07.042.","journal-title":"Int J Pharm"},{"key":"1465_CR38","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33:941\u201351. https:\/\/doi.org\/10.1038\/nbt.3330.","journal-title":"Nat Biotechnol"},{"key":"1465_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/J.IJPHARM.2022.121638","volume":"618","author":"A Varela-Moreira","year":"2022","unstructured":"Varela-Moreira A, van Leur H, Krijgsman D, Ecker V, Braun M, Buchner M, et al. Utilizing in vitro drug release assays to predict in vivo drug retention in micelles. Int J Pharm. 2022;618:121638. https:\/\/doi.org\/10.1016\/J.IJPHARM.2022.121638.","journal-title":"Int J Pharm"},{"key":"1465_CR40","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature03794","volume":"436","author":"S Sengupta","year":"2005","unstructured":"Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T, et al. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature. 2005;436:568\u201372. https:\/\/doi.org\/10.1038\/nature03794.","journal-title":"Nature"},{"key":"1465_CR41","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/NAR\/GKJ067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"a) Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 2006;34:D668\u201372. https:\/\/doi.org\/10.1093\/NAR\/GKJ067. b) DrugBank Online database can be accessed under https:\/\/go.drugbank.com [accessed on 2nd June 2023].","journal-title":"Nucleic Acids Res"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01465-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-023-01465-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-023-01465-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T08:32:43Z","timestamp":1725870763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-023-01465-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1465"],"URL":"https:\/\/doi.org\/10.1007\/s13346-023-01465-x","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,14]]},"assertion":[{"value":"22 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}